Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity
- 1 June 2007
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 337 (1-2), 346-356
- https://doi.org/10.1016/j.ijpharm.2007.01.031
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer DrugsClinical Pharmacokinetics, 2002
- Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastomaToxicology Letters, 2001
- Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast CancerJournal of Clinical Oncology, 2001
- Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain DeliveryPharmaceutical Research, 2001
- Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of actionBritish Journal of Cancer, 1997
- Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.Journal of Clinical Oncology, 1995
- Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbitCancer Chemotherapy and Pharmacology, 1993
- Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistanceBiochemical Pharmacology, 1992
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982
- Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive propertiesJournal of Pharmacy and Pharmacology, 1979